Testing

In September 2017, Mayo Medical Laboratories announced five new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

By Alyssa Frank • October 12, 2017

Mayo Clinic and National Decision Support Company unveil CareSelect Lab™ to provide real-time medical guidance when ordering clinical lab tests. The tool assists health care providers with appropriate ordering of lab testing, improving patient care and reducing wasteful spending.

By Gina Chiri-Osmond • September 19, 2017

In August 2017, Mayo Medical Laboratories announced a new test along with numerous reference value changes, obsolete tests, and algorithm changes.

By Alyssa Frank • September 14, 2017

Devin Oglesbee, Ph.D., Director of the Biochemical and Molecular Genetics Laboratories at Mayo Clinic, provides an overview of the lysosomal storage disease panel, when it is appropriate to order this test, what actions the results allow you to take, and how this test improves upon previous approaches.

By Mayo Clinic Laboratories • September 6, 2017

The algorithm can be viewed here.

By Brent Westra • August 14, 2017

This algorithm can be viewed here.

By Alyssa Frank • August 11, 2017

To ensure we continue to provide the highest level of value-based reference laboratory services, Mayo Medical Laboratories will be implementing a new pathology laboratory information system on Friday, Sept. 8, 2017. View the list of orderable pathology tests included in the system upgrade.

By Andy Tofilon • August 2, 2017

An algorithm is a step-by-step procedure to guide clinicians and laboratorians in appropriate laboratory test ordering.

By Brent Westra • July 28, 2017

The algorithm can be viewed here.

By Alyssa Frank • July 28, 2017

The algorithm can be viewed here.

By Alyssa Frank • July 1, 2017

In May 2017, Mayo Medical Laboratories announced eight brand new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

By Alyssa Frank • June 8, 2017

Clinical Laboratory News recently highlighted a Mayo Clinic study that shows how plasma ceramides may predict cardiovascular events in patients with or without coronary artery disease.

By Kelley Luedke • May 12, 2017

Useful For Assessing the patient’s probability of having detectable prostate cancer when total prostate specific antigen (PSA) concentrations are between 4–10 ng/mL. Results from a[...]

By Mayo Clinic Laboratories • May 9, 2017